STI Test Window Periods: Detection Times by Infection

There is no single STI window period. Detection timing depends on the infection and the test method used. Some infections can become detectable within roughly days (for example, HIV nucleic acid testing), while others may take weeks to months (for example, hepatitis C antibody testing). Testing too early can produce a negative result even when an infection is present — the test simply runs before there is enough of the target to detect. The ranges on this page are approximate, drawn from published CDC guidance, and should be interpreted in the context of your own exposure and symptoms rather than treated as exact cutoffs.

Count from your most recent possible exposure. Window periods should generally be counted from the most recent possible exposure relevant to your concern. If another possible exposure occurs during the waiting period, the timing calculation may need to restart from that more recent date. A clinician can help you decide what applies to your situation.

If you only want a fast answer to how many days should I wait before testing?, our quick timing guide is the better starting point: how long after exposure you should get an STD test. This page goes deeper — what a window period actually is, why detection timing differs between test methods, and when retesting makes sense.

This guide is educational only and is not a substitute for individualized medical advice, diagnosis, or treatment. If you already have symptoms, or you know you were exposed to a specific infection, talk to a clinician — do not wait for a window period to close before seeking care.

What is an STI window period?

An STI window period is the time between when a person is exposed to an infection and when a specific test can detect that infection with reasonable accuracy (per CDC). It is a property of the test, not of the person — different tests for the same infection can have different window periods because they look for different things (the pathogen's genetic material, an antigen it produces, or the antibodies your immune system makes in response).

Because tests need something detectable to find, testing during the window period can return a negative result even if an infection is present. That result is not "wrong" in a laboratory sense — the test simply ran before there was enough of the target to detect. This is why timing matters as much as choosing the right test.

A negative result taken after the appropriate window period is generally reliable for that specific test and that specific exposure (per CDC), but no test rules out infection with 100% certainty in every case. Clinicians will factor in your exposure, symptoms, and risk profile when interpreting a result. For more on how negative and positive results can be misread, see our guide to false positive and false negative STD test results.

Why detection timing differs by test method

Three broad test types are used across STI screening, and each turns positive at a different point:

• Nucleic acid amplification tests (NAATs) look for the pathogen's genetic material. They generally turn positive earliest, but the organism still has to replicate enough to be detectable, and NAATs are not used for every infection (per CDC).
• Antigen tests look for proteins the pathogen produces. Levels are often low in the earliest days after infection.
• Antibody tests look for your immune system's response. Producing measurable antibodies (seroconversion) commonly takes weeks, and the timing varies between people.

This is why "when can I test?" has no universal answer: the same exposure can be detectable by one method and invisible to another on the same day.

Window period vs. incubation period

These two terms are often used interchangeably, but they mean different things:

• Incubation period is the time between exposure and when symptoms may appear (per Cleveland Clinic).
• Window period is the time between exposure and when a test can detect the infection (per CDC).

They usually do not line up. Many STIs are asymptomatic — chlamydia and gonorrhea often cause no symptoms at all (per CDC) — so waiting for symptoms is not a reliable way to decide when to test. On the other hand, some infections can cause symptoms before an antibody-based test can pick them up, which is why a clinician-ordered NAAT may be used earlier when symptoms are present.

The practical takeaway: use window periods, not symptoms, to plan when to test after a possible exposure.

Approximate detection ranges by infection

The ranges below are approximate and probabilistic. They describe when a test becomes increasingly likely to detect an infection — not a switch that flips to "accurate" on one exact day. Your clinician may recommend earlier or later testing based on your situation, the assay used, and your exposure history. These are not personalized recommendations.

HIV

• Fourth-generation antigen/antibody blood test (Ag/Ab): typically detects HIV about 18 to 45 days after exposure (per CDC).
• Antibody-only tests can take up to 90 days to turn positive (per CDC).
• Nucleic acid tests (NAT) — usually reserved for high-risk exposures or acute symptoms — can detect HIV as early as 10 to 33 days after exposure (per CDC).

Because of this range, repeat testing at around three months is commonly advised when an initial test is negative but exposure risk was high (per CDC). If you may have had a high-risk exposure in the last 72 hours, post-exposure prophylaxis (PEP) is time-sensitive — that is a clinical decision, not a testing decision, and should be discussed with a clinician immediately (per CDC).

Chlamydia

Chlamydia is detected with a NAAT on a urine sample or a swab. CDC does not publish a single universal NAAT window period for chlamydia; in practice, many laboratories and clinicians suggest waiting roughly 1 to 2 weeks after exposure before testing, and retesting later if the exposure was recent (per CDC guidance on chlamydia testing). Because chlamydia is frequently asymptomatic (per CDC), timing the test sensibly matters more than waiting for symptoms.

Gonorrhea

Gonorrhea is also detected by NAAT, and — as with chlamydia — CDC does not define one fixed detection window. Testing roughly 1 to 2 weeks after exposure is a common practical approach, with retesting if the exposure was very recent (per CDC guidance on gonorrhea testing). Gonorrhea can be asymptomatic, especially in throat or rectal infections (per CDC), so a clinician may recommend testing at the exposed site after oral or anal exposure.

Syphilis

Syphilis is detected with blood-based antibody tests (treponemal and non-treponemal assays). Antibodies typically become detectable a few weeks after infection — commonly cited as roughly 3 to 6 weeks, and sometimes longer — so a single early test may not be conclusive and repeat testing may be advised after a significant exposure (per CDC). Because the first sign of syphilis (a painless sore called a chancre) can appear before antibodies are detectable, anyone who notices a new sore in the genital, anal, or oral area should see a clinician rather than wait for a blood test window to close (per CDC).

Trichomoniasis

Trichomoniasis is detected with a NAAT (usually on a urine sample or vaginal swab). Detection generally becomes reliable in the weeks after exposure rather than the first few days (per CDC). Trichomoniasis is one of the most common curable STIs in the U.S. but is often asymptomatic, especially in men (per CDC), so testing is often the only way to identify it.

Hepatitis B

The hepatitis B surface antigen (HBsAg) blood test generally becomes detectable in the weeks after exposure — commonly described as roughly 3 to 9 weeks — while antibody markers may take longer to appear (per CDC). CDC also describes specific post-exposure prophylaxis protocols after a known exposure; that is a clinical decision and should be discussed with a clinician (per CDC).

Hepatitis C

Hepatitis C antibody tests typically detect infection roughly 8 to 11 weeks after exposure, and antibody development can take longer in some people (per CDC). A separate HCV RNA test detects the virus itself and can turn positive substantially earlier; it is used in specific clinical situations (per CDC). Note that HCV RNA testing is a different test from the hepatitis C antibody test included in LabTestsOnDemand's standard and comprehensive panels — our panels use antibody testing, so earlier RNA detection does not apply to them.

HSV-1 / HSV-2 (herpes)

Herpes is a special case. Two things to understand:

1. Antibody blood testing has limited usefulness for asymptomatic screening. CDC does not recommend routine type-specific HSV serologic screening of the general asymptomatic population, citing accuracy limitations (per CDC).
2. When testing is used for someone with symptoms, a direct swab of the lesion with a NAAT is more accurate than a blood test. If a blood antibody test is used, seroconversion commonly takes several weeks and can take longer in some people (per CDC and ASHA).

If you have an active sore or blister you think may be herpes, see a clinician promptly — swabbing an active lesion is far more informative than waiting to time a blood test.

Why testing too early causes false negatives

A false negative during the window period is not a lab error. It is the expected behavior of the test given how it works: antibody tests need time for your immune response, antigen tests need enough protein present, and NAATs need enough replicated genetic material.

Testing before the window closes can offer false reassurance. A negative result a few days after a possible chlamydia exposure, for example, tells you very little (per CDC). Waiting until detection becomes likely — or retesting afterward — is what makes the result trustworthy.

When repeat testing is recommended

A single negative test is not always the end of the story. Repeat testing is commonly recommended in these situations (per CDC):

• HIV: repeat at around three months after a high-risk exposure if the initial test was a fourth-generation Ag/Ab test, or sooner if a NAT was used.
• Hepatitis C: repeat later if the initial antibody test was negative and exposure risk was significant.
• Syphilis: repeat after several weeks and again at around three months if the initial test was early and the exposure risk was significant.
• After treatment for chlamydia, gonorrhea, or trichomoniasis: CDC recommends retesting about three months after treatment because reinfection from an untreated partner is common (per CDC). This is a test for reinfection, not a test of cure.
• New partners or ongoing exposure: if the exposure risk did not stop with a single event, periodic retesting on a schedule your clinician recommends is more informative than one-off tests.

Cost is not a reason to delay a recommended retest. Panels are available without insurance at Labcorp locations — see STD testing cost without insurance for a plain-English breakdown of what to expect.

What to do if symptoms appear before the window closes

Symptoms change the plan. If you develop any of the following before the window period is complete, do not wait — see a clinician (per CDC and Mayo Clinic):

• New sores, ulcers, or blisters in the genital, anal, or oral area
• Unusual discharge from the penis, vagina, or rectum
• Burning or pain with urination
• Pelvic or testicular pain
• Unexplained rash, especially on the palms or soles (which can be a symptom of secondary syphilis)
• Fever, swollen lymph nodes, or flu-like symptoms after a known high-risk exposure (which can be a symptom of acute HIV)

A clinician may order tests earlier than the standard window because certain tests (like a NAAT on a swab of a lesion, or an HIV NAT) can detect infection sooner than the antibody-based versions. This is a clinical judgment, not a self-directed decision.

How window periods should shape which panel you choose

Timing and panel choice go together. Two things to think about:

1. When you test relative to your most recent exposure. If you test before detection becomes likely for the infection you're most worried about, a negative result may need to be repeated. Scheduling the test at the point when the most windows have likely closed usually gives you the most useful single snapshot (per CDC). A high-risk exposure may still warrant a three-month follow-up for HIV and hepatitis C. For day-count planning, use our how long after exposure to test guide.

2. Which infections the panel actually covers. Not every panel tests for every infection. Our Standard STI panel covers 6 key infections at Labcorp: HIV, syphilis, hepatitis B, hepatitis C, gonorrhea, and chlamydia. The Comprehensive Sexual Health Panel adds HSV-1, HSV-2, and Trichomoniasis, for 9 tests total. (Hepatitis A is not included in either panel.) For a side-by-side breakdown of what each panel covers, see our full STI panel guide.

Testing is done in person at a Labcorp draw station — if you want to know how the visit itself works before you book, see what to expect at your Labcorp STI visit.

<div class="my-8 rounded-2xl border border-primary/20 bg-primary/5 p-6"> <h3 class="mt-0 text-xl font-semibold">Ready to test at the right time?</h3> <p class="mt-2">Order a private, lab-drawn STI panel at Labcorp. Standard 6-test panel or Comprehensive 9-test panel, which adds HSV-1, HSV-2, and Trichomoniasis.</p> <p class="mt-4"><a href="/private-sti-panel" class="inline-flex items-center rounded-lg bg-accent px-5 py-3 font-semibold text-accent-foreground">See panels →</a></p> </div>

Sources

• Centers for Disease Control and Prevention — STI Treatment Guidelines, 2021
• Centers for Disease Control and Prevention — Clinical Guidance for Sexually Transmitted Infections
• Centers for Disease Control and Prevention — HIV Testing
• Centers for Disease Control and Prevention — About Chlamydia
• Centers for Disease Control and Prevention — About Gonorrhea
• Centers for Disease Control and Prevention — About Syphilis
• Centers for Disease Control and Prevention — About Trichomoniasis
• Centers for Disease Control and Prevention — Hepatitis B: Diagnosis and Testing
• Centers for Disease Control and Prevention — Hepatitis C: Diagnosis and Testing
• Centers for Disease Control and Prevention — About Genital Herpes
• Centers for Disease Control and Prevention — STI Treatment Guidelines: Genital Herpes
• American Sexual Health Association — Fast Facts About HSV (Herpes Simplex Virus)
• U.S. Preventive Services Task Force — Screening for Chlamydia and Gonorrhea
• U.S. Preventive Services Task Force — HIV Screening in Adolescents and Adults
• MedlinePlus — Sexually Transmitted Infection (STI) Tests
• Cleveland Clinic — Sexually Transmitted Infections (STIs)
• Mayo Clinic — STD Symptoms

Educational content reviewed against CDC, ASHA, USPSTF, MedlinePlus, Cleveland Clinic, and Mayo Clinic guidance. Not a substitute for individualized medical advice, diagnosis, or treatment. If you have symptoms or a known exposure to a specific infection, contact a clinician.